Marie-Claude Morice

Showing 1-20 of 64 articles

Coronary interventions

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hara H, Kawashima H, Ono M, Takahashi K, Mack M, Holmes D, Morice M, Davierwala P, Mohr F, Thuijs D, Kappetein A, O'Leary N, van Klaveren D, Onuma Y, Serruys P

October 21, 2021 | 10.4244/EIJ-D-21-00415

Geographical variations in left main coronary artery revascularisation: a pre-specified analysis of the EXCEL trial

Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown W, Serruys P, Kappetein A, Sabik J, Stone G

July 2, 2021 | 10.4244/EIJ-D-21-00338

Coronary interventions

Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients

Marquis-Gravel G, Urban P, Copt S, Capodanno D, Pocock S, Sadozai Slama S, Stoll H, Tanguay J, Mehran R, Leon M, Rao S, Morice M, Krucoff M

June 25, 2021 | 10.4244/EIJ-D-20-00749

Coronary interventions

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P

May 16, 2021 | 10.4244/EIJ-D-20-00170

Coronary interventions

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G

December 18, 2020 | 10.4244/EIJ-D-19-00686

Coronary interventions

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

October 23, 2020 | 10.4244/EIJ-D-19-01079

Coronary interventions

Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein A, Sabik J, Dressler O, Mehran R, Sharma S, Stone G

June 25, 2020 | 10.4244/EIJ-D-19-00851

Why stronger radiation safety measures are essential for the modern workforce. A perspective from EAPCI Women and Women as One

Buchanan G, Ortega R, Chieffo A, Mehran R, Gilard M, Morice M

May 20, 2020 | 10.4244/EIJV16I1A5

Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial

Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas J, Kandzari D, Banning A, Morice M, Taggart D, Sabik J, Serruys P, Kappetein A, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00263

Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee

Chieffo A, Buchanan G, Mehilli J, Capodanno D, Kunadian V, Petronio A, Mikhail G, Capranzano P, Gonzalo N, Karam N, Manzo-Silberman S, Schüpke S, Byrne R, Capretti G, Appelman Y, Morice M, Presbitero P, Radu M, Mauri Ferre J

December 7, 2018 | 10.4244/EIJ-D-18-00225

Coronary interventions

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial

Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M, Leon M, Kandzari D, Mehran R, Lembo N, Banning A, Merkely B, Kappetein A, Sabik J, Serruys P, Stone G

November 20, 2018 | 10.4244/EIJ-D-18-00711

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson T, Hill J, Hussein H, Bogaerts K, Morice M, Foley DP

June 14, 2018 | 10.4244/EIJ-D-18-00346

Stable CAD

The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial

Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein A

May 20, 2018 | 10.4244/EIJ-D-17-00620

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial

Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iñiguez A, Nazzaro M, Oldroyd K, Talwar S, Richardt G, Windhovel U, Urban P, Morice M

February 20, 2018 | 10.4244/EIJ-D-17-00286

Coronary interventions

Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?

Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein A, Mohr F, Colombo A, Feldman T, Morice M

September 20, 2017 | 10.4244/EIJ-D-16-00991

Coronary interventions

Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes

Sanguineti F, Garot P, O’Connor S, Watanabe Y, Spaziano M, Lefèvre T, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Morice M, Louvard Y

February 3, 2017 | 10.4244/EIJ-D-15-00278

Coronary interventions

The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study

Varenne O, Cuisset T, Chaib A, Morice M, Sabaté M, Koh T-H, Durand-Zaleski I, Hanon O, Bogaerts K, Sinnaeve P

January 20, 2017 | 10.4244/EIJY15M12_02

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein A, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G

September 18, 2016 | 10.4244/EIJV12I7A141

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.